Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.

Journal of neuropathology and experimental neurology - 1 Dec 2001

Wolter M, Reifenberger J, Blaschke B, Ichimura K, Schmidt E E, Collins V P, Reifenberger G

Abstract excerpt

We investigated 34 oligodendroglial tumors (7 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 8 oligoastrocytomas, and 8 anaplastic oligoastrocytomas) for deletion, mutation, hypermethylation, and expression of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes at 9p21. One anaplastic oligoastrocytoma carried a homozygous deletion including all 3 genes. None of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Cyclin-Dependent Kinase Inhibitor p15

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Genes, p16

Share to Genes, Tumor Suppressor

Share to Oligodendroglioma

Share to Ribosomal Proteins

Share to Tumor Suppressor Protein p14ARF

Source

Identifiers

PMID: 11764089
DOI: 10.1093/jnen/60.12.1170

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.PMID 11764089Read ↗

Concurrent Hypermethylation of Multiple Genes Is Associated with Grade of Oligodendroglial TumorsSemantic proximity Read ↗

Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas.Semantic proximity Read ↗

Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumorsSemantic proximity Read ↗

Pathology and molecular genetics of oligodendroglial tumors.Semantic proximity Read ↗

Frequent promoter hypermethylation and low expression of the <i>MGMT</i> gene in oligodendroglial tumorsSemantic proximity Read ↗

DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.Semantic proximity Read ↗

Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.Semantic proximity Read ↗

Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomasSemantic proximity Read ↗

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.Semantic proximity Read ↗

Whole-genomic survey of oligodendroglial tumors: correlation between allelic imbalances and gene expression profiles.Semantic proximity Read ↗

Molecular pathology of oligodendroglial tumors.Semantic proximity Read ↗

[Molecular biology of oligodendroglial tumors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.